Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: ReQuip
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ReQuip XL 8mg tablets
0409010H0BBAIAM
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 2,708 |
|
ReQuip XL 2mg tablets
0409010H0BBAGAK
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 2,382 |
|
ReQuip XL 4mg tablets
0409010H0BBAHAL
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 2,023 |
|
ReQuip 1mg tablets
0409010H0BBABAB
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 584 |
|
ReQuip 2mg tablets
0409010H0BBACAC
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 391 |
|
ReQuip 250microgram tablets
0409010H0BBAAAA
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 63 |
|
ReQuip 5mg tablets
0409010H0BBADAD
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | 50 |
|
ReQuip tablets follow on pack
0409010H0BBAEAE
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | No data available |
|
ReQuip tablets starter pack
0409010H0BBAFAF
|
ReQuip | Ropinirole hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.